Congressional ‘Cures’ Debate Shifts To FDA Funding
This article was originally published in The Pink Sheet Daily
Executive Summary
House Democrats say FDA will need more money to be able to handle the responsibilities in the draft bill, while the agency worries reviews could slow without more resources.